XO1's Acquisition

XO1 was acquired by Janssen Pharmaceuticals on March 19, 2015.

XO1 is a biotechnology company formed specifically to develop ichorcumab. It is a virtual company, with no offices or laboratory space, and operates by engaging high quality contract research and deve…

Articles about XO1's Acquisition: